Preliminary reports show that Miller Gardner, the 14-year-old son of Yankees outfielder Brett Gardner, may have died from ...

A fitness bet turned dangerous for a Vladivostok man after completing 2,000 squats led to acute kidney failure. Despite ...

Berikut adalah penjelasan tentang tips dan cara menaikkan trombosit pada anak, makanan yang harus dihindari, serta supplemen ...

The life-limiting condition affects around 800 people in the UK, with symptoms starting in adulthood ... of the rare disease atypical haemolytic uremic syndrome, moving faster than NICE and ...

The FDA on Thursday approved Fabhalta (iptacopan) to treat complement 3 glomerulopathy (CG3), a progressive, ultrarare kidney ...

People living with C3G may experience high levels of fatigue, mobility issues affecting everyday life activities, and mental health symptoms ... atypical hemolytic uremic syndrome (aHUS), immune ...

Soon-to-be medical school graduates received 877 more primary care position offers in the 2025 Main Residency Match compared with the previous year, according to the National Resident Matching ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Phase III study showed sustained proteinuria reduction at one yea ...

Novartis Media Relations E-mail: media.relations@novartis.com Novartis Investor Relations Central investor relations line: +41 61 ...

Basel: Novartis has announced that the U.S. Food and Drug Administration (FDA) has approved oral Fabhalta (iptacopan) for the ...

US FDA approves Novartis’ oral Fabhalta for treatment of adults with C3 glomerulopathy: Basel Saturday, March 22, 2025, 09:00 Hrs [IST] Novartis announced that oral Fabhalta (ip ...